Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
First U.S. citizen detained as China pharma probe spreads
Source: Reuters
First U.S. citizen detained as China pharma probe spreads
By Michael Martina
BEIJING | Tue Jul 23, 2013 11:15am EDT
(Reuters) - The first U.S. citizen has been detained in China in connection with probes sparked by an unfolding corruption scandal in the drugs industry, as China widens the range of international firms and staff under the spotlight.
Police have also questioned two further Chinese employees from drug maker AstraZeneca in Shanghai, after a local sales representative was taken away for questioning earlier.
And China's health ministry said 39 hospital staff would be punished for taking bribes from drug companies.
The unnamed American is the first U.S. citizen to be detained in connection with the investigations, and the second foreign national, after a British risk consultant linked with GlaxoSmithKline was held last week.
[font size=1]-snip-[/font]
By Michael Martina
BEIJING | Tue Jul 23, 2013 11:15am EDT
(Reuters) - The first U.S. citizen has been detained in China in connection with probes sparked by an unfolding corruption scandal in the drugs industry, as China widens the range of international firms and staff under the spotlight.
Police have also questioned two further Chinese employees from drug maker AstraZeneca in Shanghai, after a local sales representative was taken away for questioning earlier.
And China's health ministry said 39 hospital staff would be punished for taking bribes from drug companies.
The unnamed American is the first U.S. citizen to be detained in connection with the investigations, and the second foreign national, after a British risk consultant linked with GlaxoSmithKline was held last week.
[font size=1]-snip-[/font]
Read more: http://www.reuters.com/article/2013/07/23/us-gsk-china-idUSBRE96K07020130723